PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 232 filers reported holding PDL BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 1.63 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $640,000 | -46.6% | 203,669 | -39.8% | 0.03% | -71.1% |
| Q4 2015 | $1,198,000 | +29.9% | 338,293 | +84.6% | 0.10% | +11.5% |
| Q3 2015 | $922,000 | +85.9% | 183,242 | +137.7% | 0.09% | +26.1% |
| Q2 2015 | $496,000 | +39.7% | 77,092 | +52.6% | 0.07% | -25.8% |
| Q1 2015 | $355,000 | +171.0% | 50,532 | +197.4% | 0.09% | +126.8% |
| Q4 2014 | $131,000 | -62.7% | 16,992 | -63.8% | 0.04% | -71.1% |
| Q3 2014 | $351,000 | – | 46,957 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |